Trademark: 97923395
Word
EVICORE SMARTCHOICE LAB
Status
Pending
Status Code
681
Status Date
Wednesday, April 10, 2024
Serial Number
97923395
Mark Type
4000
Filing Date
Friday, May 5, 2023
Published for Opposition
Tuesday, May 14, 2024

Trademark Owner History

Classifications
38 Electronic data interchange services; Electronic data interchange services in the field of healthcare transactions such as claims, eligibility, claim status, electronic remittance advice, prior authorizations, attachments and referrals that allow direct transaction, authorization and payment communications between healthcare providers, patients and payers; providing access to databases in the fields of medical diagnosis guidance and evidence-based healthcare
36 Medical benefit management services; medical benefit management services, namely, tracking, monitoring, assessing and analyzing information and statistics regarding patient prescription drug use, medical care, and healthcare habits, to identify potential cost savings and clinical benefits; claims administration services in the field of health insurance; medical insurance case and utilization review and insurance claims adjustment services for healthcare purchasers, payers, providers, and beneficiaries of health plans; administration of managed health care plans; consulting services regarding healthcare plan benefits
35 Medical cost management; managed care services, namely, utilization review and pre-certification and post-certification services in the fields of inpatient admission management, molecular genomic lab services, comprehensive lab services, and diagnostic lab services, specialty drug medical benefit; cost management for the health care benefit plans of others; managed care services, namely, electronic processing of health care information; organization and coordination of health care services, namely, appointment coordination services and arranging managed care contractual services in the fields of diagnostic imaging, advanced imaging, nuclear medicine, radiation therapy, medical oncology medical benefit, medical oncology pharmacy benefit, cardiac and nuclear cardiac imaging, echo stress testing, diagnostic heart catheterization, ultrasound services, sleep management testing and treatment, sleep diagnostics, pap therapy devices and supplies, therapy support services, cardiac device care, post-acute care management, durable medical equipment, home infusion, bundled payments, musculoskeletal care, spine surgery, joint surgery, interventional pain, implant management, inpatient admission management, molecular genomic lab services, comprehensive lab services, and diagnostic lab services, gastroenterology, upper endoscopy, colonoscopy, lower endoscopy, capsule endoscopy, specialty drug medical benefit, occupational therapy, physical therapy, speech therapy, chiropractic care, acupuncture, massage therapy, and opioid management; evidenced-based health care cost management services and healthcare utilization and review services; managed care services, namely, electronic processing of health care information via the internet; health care cost management services for healthcare benefit plans of others and risk-bearing provider organizations being medical cost management services; analyzing and compiling business data, namely, tracking, monitoring, assessing and analyzing information and statistics regarding patient prescription drug use, medical care, and healthcare habits, to identify potential cost savings and clinical benefits; collection and analysis of quality metric data for health care providers and health care payors for business purposes
42 Software as a service (SAAS) services featuring software for use in connection with evidence-based healthcare and insurance, namely, the development and implementation of algorithms and analytical models from evidence-based medical criteria for purposes of a medical utilization review and reporting, and verifying the requesting provider's adherence to evidence-based medicine guidelines and determining the appropriate intensity of medical utilization review based upon the requesting provider's prior history; application service provider (ASP), featuring software for use in developing, analyzing, and maintaining information and database management in the fields of healthcare, benefits programs, employee productivity, and risk management; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control in the field of healthcare benefit plans for others; molecular and genetic lab services; software as a service (SAAS) services featuring software for optimizing healthcare utilization, managing utilization and financial risk for healthcare payers, assisting physicians in making clinical decision, and analyzing data to help health care providers track clinical decisions and develop best practices; software as a service (saas) services featuring software for use in automating tasks and storing data in the field of healthcare; providing online internet based non-downloadable computer software to perform prior authorizations services for healthcare providers and payers; providing online non-downloadable software for use by healthcare providers to search and retrieve clinical and non-clinical data from electronic medical records; computer services, namely, providing a cloud-enabled service in the nature of providing temporary use of non-downloadable cloud-based software for others that automates the prior authorization process for medical benefits; providing online non-downloadable software for use in obtaining prior authorizations; providing temporary use of online non-downloadable computer software for health risk assessment and profiling for use in the field of preventive health
EVICORE SMART CHOICE LAB
lab

Trademark Events
Apr 6, 2024
Approved For Pub - Principal Register
Apr 5, 2024
Teas/Email Correspondence Entered
Apr 5, 2024
Correspondence Received In Law Office
Apr 5, 2024
Teas Response To Office Action Received
Feb 8, 2024
Notification Of Non-Final Action E-Mailed
Feb 8, 2024
Non-Final Action E-Mailed
Feb 8, 2024
Non-Final Action Written
Jan 30, 2024
Assigned To Examiner
Jun 5, 2023
New Application Office Supplied Data Entered
May 9, 2023
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24